Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Flack

Showing results (241-250 of 263) with videos related to

Pageof 27
Sort By:
Kidney Medicine|December 4, 2023
Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD TrialsJohn M Flack, Rajiv Agarwal, Stefan D Anker, et al.
Hypertension (Dallas, Tex. : 1979)|December 30, 2015
Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort StudyGeorge Thomas, Dawei Xie, Hsiang-Yu Chen, et al.
The New England Journal of Medicine|April 23, 2025
Lorundrostat Efficacy and Safety in Patients with Uncontrolled HypertensionLuke J Laffin, Branko Kopjar, Carrie Melgaard, et al.
Journal of the American College of Cardiology|May 27, 2014
Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3George L Bakris, Raymond R Townsend, Minglei Liu, et al.
The New England Journal of Medicine|April 1, 2014
A controlled trial of renal denervation for resistant hypertensionDeepak L Bhatt, David E Kandzari, William W O'Neill, et al.
Clinical Cardiology|May 11, 2012
Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 TrialDavid E Kandzari, Deepak L Bhatt, Paul A Sobotka, et al.
Chemsuschem|November 9, 2013
Design, synthesis, and evaluation of nonaqueous silylamines for efficient CO2 captureJackson R Switzer, Amy L Ethier, Emily C Hart, et al.
Journal of the American College of Cardiology|April 4, 2015
12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trialGeorge L Bakris, Raymond R Townsend, John M Flack, et al.
American Journal of Hypertension|February 28, 2002
Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trialJohn B Kostis, Stuart Cobbe, Colin Johnston, et al.
Hypertension (Dallas, Tex. : 1979)|October 6, 2010
Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statementJohn M Flack, Domenic A Sica, George Bakris, et al.
Pageof 27

Showing results (241-250 of 263) with videos related to

Sort By:
Pageof 27
Kidney Medicine|December 4, 2023
Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD TrialsJohn M Flack, Rajiv Agarwal, Stefan D Anker, et al.
Hypertension (Dallas, Tex. : 1979)|December 30, 2015
Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort StudyGeorge Thomas, Dawei Xie, Hsiang-Yu Chen, et al.
The New England Journal of Medicine|April 23, 2025
Lorundrostat Efficacy and Safety in Patients with Uncontrolled HypertensionLuke J Laffin, Branko Kopjar, Carrie Melgaard, et al.
Journal of the American College of Cardiology|May 27, 2014
Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3George L Bakris, Raymond R Townsend, Minglei Liu, et al.
The New England Journal of Medicine|April 1, 2014
A controlled trial of renal denervation for resistant hypertensionDeepak L Bhatt, David E Kandzari, William W O'Neill, et al.
Clinical Cardiology|May 11, 2012
Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 TrialDavid E Kandzari, Deepak L Bhatt, Paul A Sobotka, et al.
Chemsuschem|November 9, 2013
Design, synthesis, and evaluation of nonaqueous silylamines for efficient CO2 captureJackson R Switzer, Amy L Ethier, Emily C Hart, et al.
Journal of the American College of Cardiology|April 4, 2015
12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trialGeorge L Bakris, Raymond R Townsend, John M Flack, et al.
American Journal of Hypertension|February 28, 2002
Design of the Omapatrilat in Persons with Enhanced Risk of Atherosclerotic events (OPERA) trialJohn B Kostis, Stuart Cobbe, Colin Johnston, et al.
Hypertension (Dallas, Tex. : 1979)|October 6, 2010
Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statementJohn M Flack, Domenic A Sica, George Bakris, et al.
Pageof 27